Maryland State Retirement & Pension System’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
8,792
+225
+3% +$23.5K 0.02% 533
2026
Q1
$903K Sell
8,567
-36
-0.4% -$3.19K 0.02% 537
2025
Q4
$751K Buy
8,603
+196
+2% +$16K 0.02% 612
2025
Q3
$558K Sell
8,407
-9,809
-54% -$558K 0.01% 740
2025
Q2
$1.01M Buy
18,216
+818
+5% +$39.3K 0.02% 569
2025
Q1
$841K Sell
17,398
-2,772
-14% -$116K 0.02% 630
2024
Q4
$779K Buy
20,170
+278
+1% +$12.1K 0.02% 791
2024
Q3
$895K Buy
+19,892
New +$804K 0.02% 721

Other funds holding PTGX

Maryland State Retirement & Pension System's PTGX Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Protagonist Therapeutics (PTGX) stake by 2.6% in Q2 2026, buying an estimated $23.5K and bringing the position to 8,792 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #533.

Maryland State Retirement & Pension System first reported a position in PTGX in Q3 2024 and has held it in 8 quarters since. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Maryland State Retirement & Pension System held 8,792 shares of Protagonist Therapeutics worth $1.08M as of Q2 2026.
  • Maryland State Retirement & Pension System bought 225 Protagonist Therapeutics shares in Q2 2026, an estimated $23.5K.
  • Protagonist Therapeutics made up 0.02% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #533 holding.
  • Maryland State Retirement & Pension System first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.